49 related articles for article (PubMed ID: 8820034)
1. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
Wong EKS; Marchbank KJ; Lomax-Browne H; Pappworth IY; Denton H; Cooke K; Ward S; McLoughlin AC; Richardson G; Wilson V; Harris CL; Morgan BP; Hakobyan S; McAlinden P; Gale DP; Maxwell H; Christian M; Malcomson R; Goodship THJ; Marks SD; Pickering MC; Kavanagh D; Cook HT; Johnson SA;
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1639-1651. PubMed ID: 34551983
[TBL] [Abstract][Full Text] [Related]
2. Morphological and etiological analyses of C3 and non-C3 glomerulonephritis in primary membranoproliferative glomerulonephritis using periodic acid-methenamine silver stain electron microscopy: a retrospective multicentered study.
Honma S; Sato N; Sakaguchi R; Hashiguchi A; Uesugi N; Nakamura Y; Sasano H; Joh K
Med Mol Morphol; 2024 Mar; 57(1):23-34. PubMed ID: 37823929
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulopathy in Japanese children.
Ueda C; Horinouchi T; Inoki Y; Ichikawa Y; Tanaka Y; Kitakado H; Kondo A; Sakakibara N; Nagano C; Yamamura T; Fujimura J; Kamiyoshi N; Ishimori S; Ninchoji T; Kaito H; Shima Y; Iijima K; Nozu K; Yoshikawa N
Pediatr Nephrol; 2024 Apr; ():. PubMed ID: 38662234
[TBL] [Abstract][Full Text] [Related]
4. The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
Afolabi H; Zhang BM; O'Shaughnessy M; Chertow GM; Lafayette R; Charu V
Am J Kidney Dis; 2024 Jan; 83(1):79-89. PubMed ID: 37739026
[TBL] [Abstract][Full Text] [Related]
5. Demographics and treatment of patients with primary membranoproliferative glomerulonephritis in Japan using a national registry of clinical personal records.
Nakagawa N; Kimura T; Sakate R; Isaka Y; Narita I
Clin Exp Nephrol; 2023 Nov; 27(11):928-935. PubMed ID: 37515698
[TBL] [Abstract][Full Text] [Related]
6. Membranoproliferative Glomerulonephritis Type I Associated with Intravenous Immunoglobulin Administration Arising in a Child with X-Linked Agammaglobulinemia: A Case Report and a Reappraisal.
Hussein MRA; Babiker M; Asim S; Elsamwal M
Saudi J Kidney Dis Transpl; 2023 Nov; 34(6):660-665. PubMed ID: 38725215
[TBL] [Abstract][Full Text] [Related]
7. Use of a B-cell depleting regimen for antifactor H autoantibody-mediated membranoproliferative glomerulonephritis in a paediatric patient.
Henderson S; Ardill R; Reynolds B; Kavanagh D
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35444020
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin glomerulopathy in a kidney allograft biopsy.
Klair N; Mahmood SB; El-Rifai R; Nast CC; Bu L; Bregman A
BMC Nephrol; 2023 Dec; 24(1):359. PubMed ID: 38053039
[TBL] [Abstract][Full Text] [Related]
9. Iptacopan in Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study.
Vivarelli M; Bomback AS; Meier M; Wang Y; Webb NJA; Veldandi UK; Smith RJH; Kavanagh D
Kidney Int Rep; 2024 Jan; 9(1):64-72. PubMed ID: 38312795
[TBL] [Abstract][Full Text] [Related]
10. Functional Magnetic Resonance Imaging to Monitor Disease Progression: a prospective study in Patients with Primary Membranoproliferative Glomerulonephritis.
Villa G; Daina E; Brambilla P; Gamba S; Leone VF; Carrara C; Rizzo P; Noris M; Remuzzi G; Remuzzi A; Caroli A
Nephron; 2023 Nov; ():. PubMed ID: 37926085
[TBL] [Abstract][Full Text] [Related]
11. The need for renal biopsy in oncology patients on check-point inhibitors check-point inhibitors: New triggers for extracapillary glomerulonephritis extracapillary glomerulonephritis.
Sanchez de la Nieta Garcia MD; Juez Del Pozo A; Cortés Toro JA; Rodríguez Moreno A; García Carro C; Ruiz Ferreras E; Sánchez Fructuoso AI
Nefrologia (Engl Ed); 2023 Dec; 43 Suppl 2():108-110. PubMed ID: 38245441
[No Abstract] [Full Text] [Related]
12. Microscopic Hematuria in C3G and IC-MPGN.
Caravaca-Fontán F; Praga M
Nephrol Dial Transplant; 2024 Apr; ():. PubMed ID: 38688873
[No Abstract] [Full Text] [Related]
13. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
14. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk.
Little MA; Dupont P; Campbell E; Dorman A; Walshe JJ
Kidney Int; 2006 Feb; 69(3):504-11. PubMed ID: 16395262
[TBL] [Abstract][Full Text] [Related]
15. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
16. [Sibling cases of nephritis resembling membranoproliferative glomerulonephritis].
Ueda H; Isimura E; Okuno S; Maekawa K; Izumotani T; Kim M; Matsumoto N; Fukumoto S; Imanishi Y; Emoto M; Shoji T; Wanibuchi H; Inaba M; Nishizawa Y
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):420-6. PubMed ID: 12073629
[TBL] [Abstract][Full Text] [Related]
17. De novo membranoproliferative glomerulonephritis III in a renal transplant patient: case report and review of the literature.
Java A; Gaut JP; Brennan DC
Transpl Int; 2012 May; 25(5):e58-61. PubMed ID: 22380572
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
